Fidaxomicin for the Treatment of Clostridioides Difficile in Children is a research paper published in Future Microbiology (2020). On theSindex it has a DataRank of 0.269. It has been cited 5 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →the National Institute of Allergy and Infectious Diseases
Grant: K23AI123525, R21AI144549, and R03AI149000
NIAID NIH HHS
Grant: K23 AI123525
NIAID NIH HHS
Grant: R03 AI149000
NIAID NIH HHS
Grant: R21 AI144549
National Institutes of Health
Grant: 5R21AI144549-02
Clostridium innocuum as an emerging multidrug-resistant antibiotic-associated diarrheal pathogen
National Institutes of Health
Grant: 5K23AI123525-04
Optimizing the diagnosis of pediatric Clostridium difficile infection
National Institutes of Health
Grant: 1R03AI149000-01A1
Identifying the Breadth of Antibody Responses to Clostridioides difficile Infection
Merck
FWCI
0.00
Citation Percentile
0.1%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals